Vascular dysfunction elicited by a cross talk between periaortic adipose tissue and the vascular wall is reversed by pioglitazone

Detecting human coronary inflammation by imaging perivascular fat

(2017) Alexios S. Antonopoulos et al.   Science Translational Medicine

Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease

(2016) José J. Fuster et al.   CIRCULATION RESEARCH

Role of Perivascular Adipose Tissue on Vascular Reactive Oxygen Species in Type 2 Diabetes: A Give-and-Take Relationship: Figure 1

(2015) Jaume Padilla et al.   DIABETES

Adiponectin as a Link Between Type 2 Diabetes and Vascular NADPH Oxidase Activity in the Human Arterial Wall: The Regulatory Role of Perivascular Adipose Tissue

(2015) Alexios S. Antonopoulos et al.   DIABETES

Perivascular Adipose Tissue in Vascular Function and Disease

(2014) Nicholas K. Brown et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression

(2014) B. Cannizzo et al.   FREE RADICAL RESEARCH

Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima–media thickness

(2013) Changhong Tan et al.   ATHEROSCLEROSIS

The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus

(2013) Hanford Yau et al.   Current Diabetes Reports

Pioglitazone enhances the blood pressure-lowering effect of losartan via synergistic attenuation of angiotensin II-induced vasoconstriction

(2013) Xiang Kong et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

PPAR Agonist-Induced Reduction of Mcp1 in Atherosclerotic Plaques of Obese, Insulin-Resistant Mice Depends on Adiponectin-Induced Irak3 Expression

(2013) Maarten Hulsmans et al.   PLoS One

Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction

(2013) Ping Gu et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Insulin Resistance Promotes Early Atherosclerosis via Increased Proinflammatory Proteins and Oxidative Stress in Fructose-Fed ApoE-KO Mice

(2012) Beatriz Cannizzo et al.   Experimental Diabetes Research

Local Gene Silencing of Monocyte Chemoattractant Protein-1 Prevents Vulnerable Plaque Disruption in Apolipoprotein E-Knockout Mice

(2012) Xiao Ling Liu et al.   PLoS One

Review of approved pioglitazone combinations for type 2 diabetes

(2011) Thomas Forst et al.   EXPERT OPINION ON PHARMACOTHERAPY

Adipokines in Periaortic and Epicardial Adipose Tissue: Differential Expression and Relation to Atherosclerosis

(2011) Sofia G. Spiroglou et al.   Journal of Atherosclerosis and Thrombosis

Pioglitazone Suppresses Inflammation In Vivo in Murine Carotid Atherosclerosis

(2010) Kiyuk Chang et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Early alterations in vascular contractility associated to changes in fatty acid composition and oxidative stress markers in perivascular adipose tissue

(2010) Alejandro Rebolledo et al.   Cardiovascular Diabetology

Periadventitial Adipose Tissue Promotes Endothelial Dysfunction via Oxidative Stress in Diet-Induced Obese C57Bl/6 Mice

(2010) Juha Ketonen et al.   CIRCULATION JOURNAL

Crosstalk between perivascular adipose tissue and blood vessels

(2010) Srinivas Rajsheker et al.   CURRENT OPINION IN PHARMACOLOGY

Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans

(2009) Sheng Wen Liu et al.   CLINICAL ENDOCRINOLOGY

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis

(2009) Amalia Gastaldelli et al.   HEPATOLOGY

The Metabolic Syndrome

(2008) Marc-Andre Cornier et al.   ENDOCRINE REVIEWS